| Application no. and date | 01953272.0 (espacenet) (Federated) (European Patent Register), 20010803 | | Patent/reg. no. and date | DK/EP 1305329, 20071205 | | Publication date | 20030502 | | Priority no. and date | GB 0019172, 20000805, GB 0108800, 20010407 | | EP pub. no. and date |
EP 1305329 20030502 | | Effective date | | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | | Applicant ref. no. | 151519 | | Inventor | BIGGADIKE, Keith, GlaxoSmithKline,
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY, GB,
COOTE, Steven, John, GlaxoSmithKline,
Gunnels Wood Road
Stevenage,
Hertfordshire SG1 2NY, GB,
NICE, Rosalyn, Kay, GlaxoSmithKline,
Gunnels Wood Road
Stevenage,
Hertfordshire SG1 2NY, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/58 (2006.01) , A61P 11/06 (2006.01) , A61P 11/08 (2006.01) , A61P 5/44 (2006.01) , C07J 17/00 (2006.01) , C07J 31/00 (2006.01) | | Title | 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel | | Int. application no. | GB2001003495 | | Int. publication no. | WO2002012265 | | Related patent (certificate) | CA 2008 00022 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
